FDA accepted for review an sNDA for MIUDELLA copper IUD for a 6-year duration, with a PDUFA date in Q2 2027.

Take a look back at some of the top FDA and pipeline news in women's health from August 2026.

The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

A new SFP Committee Statement in Contraception standardizes protocols for removing deep and nonpalpable contraceptive implants.

Atogepant reduced perimenstrual migraine days vs. placebo and met all 8 secondary endpoints in the Phase 3 LUNA study.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.